info@seagull-health.com
SeagullHealth
语言:
search
new
Indications of Perfluorohexyl Octane Eye Drops (Miebo)
503
Article source: Seagull Pharmacy
Nov 11, 2025

Perfluorohexyl Octane Eye Drops (Miebo) is a new ophthalmic therapeutic drug approved by the U.S. Food and Drug Administration (FDA) in 2023, providing an innovative treatment option for patients with dry eye disease.

Indications of Perfluorohexyl Octane Eye Drops (Miebo)

Targeted Treatment for Dry Eye Disease

Perfluorohexyl Octane Eye Drops are specifically used to treat the signs and symptoms of dry eye disease.

This drug has been verified through rigorous clinical trials and is mainly intended for patient populations with a history of dry eye disease and accompanying clinical symptoms of meibomian gland dysfunction.

Specifications and Properties of Perfluorohexyl Octane Eye Drops (Miebo)

Basic Physical Properties

Perfluorohexyl Octane Eye Drops are a sterile, clear and colorless ophthalmic solution, with the active ingredient content being 100% perfluorohexyl octane.

The chemical name of this semifluorinated alkane is 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane.

Molecular Structure Characteristics

The molecular formula of the active ingredient is C₁₄H₁₇F₁₃, and its molecular weight is 432.26 g/mol.

In terms of physicochemical properties, perfluorohexyl octane is almost immiscible with water, but it is miscible with ethanol and most organic solvents.

Packaging Specifications

Each multi-dose bottle contains 3 mL of perfluorohexyl octane, with a density of 1.338 g/mL, presenting as a clear and colorless liquid.

The drug is packaged in a 5 mL polypropylene bottle for multiple uses, equipped with a dropper tip and a screw cap.

Storage Methods of Perfluorohexyl Octane Eye Drops (Miebo)

Temperature Control Requirements

Perfluorohexyl Octane Eye Drops should be stored at a temperature of 15ºC to 25ºC (59ºF to 77ºF).

This storage temperature range ensures that the drug maintains stability and therapeutic efficacy throughout its shelf life.

Usage Period After Opening

After the drug bottle is opened, the drug can continue to be used within the expiration date marked on the bottle.

Proper Storage Practices

To ensure the quality of the drug, it should be stored away from extreme temperature environments, including freezing or exposure to high-temperature conditions.

At the same time, the bottle cap should be kept tightly closed to prevent contamination and evaporation.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase Perfluorohexyl Octane Eye Drops (Miebo)
Perfluorohexyl Octane Eye Drops (Miebo) is a new dry eye treatment drug approved in 2023. Its unique evaporation-inhibiting effect provides a new option for patients with dry eye syndrome.How to Purch...
Precautions for Wayrilz (Rezabrutinib) Administration
Wayrilz (Rezabrutinib) is a Bruton's Tyrosine Kinase inhibitor, first approved in the United States in 2025. It is primarily indicated for the treatment of persistent or chronic immune thrombocyto...
What Are the Side Effects of Wayrilz (Rezabrutinib)?
Wayrilz (Rezabrutinib) is an oral Bruton's Tyrosine Kinase inhibitor. Approved by the U.S. FDA in 2025, it is indicated for the treatment of persistent or chronic immune thrombocytopenia in adults...
How to Purchase Wayrilz (Rezabrutinib)
Wayrilz (Rezabrutinib) is a novel Bruton's Tyrosine Kinase (BTK) inhibitor. Approved in the United States in 2025, it is indicated for the treatment of persistent or chronic immune thrombocytopeni...
How to Use Perfluorohexyl Octane Eye Drops (Miebo)
Perfluorohexyl Octane Eye Drops (Miebo) is a semifluorinated alkane ophthalmic solution. It was first approved in the United States in 2023 and is specifically used to treat the signs and symptoms of ...
Precautions for Using Perfluorohexyl Octane Eye Drops (Miebo)
Perfluorohexyl Octane Eye Drops (Miebo) is a new type of semifluorinated alkane eye drops. Approved in the United States in 2023, it is specifically used to treat the signs and symptoms of dry eye dis...
What Are the Side Effects of Perfluorohexyl Octane Eye Drops (Miebo)?
Perfluorohexyl Octane Eye Drops (Miebo) is a new dry eye treatment drug approved in the United States in 2023, with its active ingredient being 100% perfluorohexyl octane.What Are the Side Effects of ...
How to Purchase Cobenfy (KarXT)
Cobenfy (KarXT) is a new antipsychotic drug approved in 2024. Its dual mechanism of action provides a new option for patients with schizophrenia. As a strictly controlled prescription drug, standardiz...
Related Articles
Ibrutinib (Imbruvica): Side Effects, Management Strategies and Storage Guidelines
Ibrutinib (Imbruvica) is a Bruton's tyrosine kinase (BTK) inhibitor indicated for the treatment of various B-cell malignancies and chronic graft-versus-host disease (cGVHD).I. Common Side EffectsT...
Medication Guide and Healthy Living Advice for Ibrutinib (Imbruvica)
Ibrutinib is a kinase inhibitor indicated for the treatment of various B-cell malignancies and chronic graft-versus-host disease (cGVHD).1. Standard Dosage and Administration1.1 For Adult Patients wit...
​Enasidenib: Indications, Contraindications, and Dosage Guidelines for Special Populations
Enasidenib is a targeted agent against IDH2 mutations, used for the precise treatment of specific types of acute myeloid leukemia.I. Indications: Precision Targeting of IDH2 Mutations1. Sole Indicatio...
Complete Analysis of Enasidenib: Mechanism of Action, Drug Interactions, and Missed Dose Management
Enasidenib is an oral targeted therapy indicated for relapsed or refractory acute myeloid leukemia with IDH2 mutations.I. What is Enasidenib?1. Drug Profile(1) Enasidenib (brand name: IDHIFA) is an is...
Enasidenib: Dosage, Precautions, and Healthy Lifestyle Guidelines
Proper administration of enasidenib, avoidance of treatment risks, and adoption of a healthy lifestyle are critical to enhancing therapeutic efficacy and ensuring safety.1. Dosage and Administration1....
Enasidenib: Side Effects, Management Strategies, and Storage Guidelines
While treating IDH2-mutant acute myeloid leukemia (AML), enasidenib may cause various adverse reactions.I. Common Side Effects of Enasidenib1. Adverse Reactions with an Incidence Rate ≥ 20%Based on cl...
Dosage and Administration, Precautions, and Healthy Lifestyle for Cenobamate
Cenobamate is a novel once-daily oral antiepileptic drug. Correct dosage and administration, strict adherence to precautions, and a healthy lifestyle are critical to ensuring its efficacy and safety.I...
Side Effects of Cenobamate and Management Strategies
Cenobamate is an effective novel antiepileptic drug, but it is associated with a range of side effects.I. Side Effects of Cenobamate1. Most Common Side Effects (Incidence ≥10% and higher than placebo)...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved